leisure time -WSS

leisure time

author：hotspot 2025-09-27 23:52:04 - browse：7

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

hotspot

explore

WSS

In utero gene editing: an explainer

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Obesity drugs seen as possible treatment for liver disease MASH

Fetal surgery at risk from Dobbs and new abortion restrictions

Cigna, Humana reportedly in talks to merge

focus

leisure time

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

With competition flaring, obesity drug hits goal in liver disease study

How one medical school became remarkably diverse

With competition flaring, obesity drug hits goal in liver disease study

Apple is now the first public company to be valued at $3 trillion

Mayo Clinic plans $5B tech

Malaria cases in Florida and Texas: Here’s what you need to know

Community Health Systems hospitals under DOJ investigation

Bright Health sells Medicare Advantage business to Molina

What don’t we know about an Alzheimer’s drug side effect?

explore

Will the market for weight loss drugs really reach $100 billion?

ReNAgade cuts staff seven months after raising $300 million

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

With clinical trial data readouts, here's how to spot spin

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Why palliative psychiatry is worth discussing

knowledge

hotspot

explore

knowledge